240 related articles for article (PubMed ID: 29774442)
1. Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
Rich KM; Bia J; Altice FL; Feinberg J
Curr HIV/AIDS Rep; 2018 Jun; 15(3):266-275. PubMed ID: 29774442
[TBL] [Abstract][Full Text] [Related]
2. Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions.
Taweh N; Schlossberg E; Frank C; Nijhawan A; Kuo I; Knight K; Springer SA
Int J Drug Policy; 2021 Oct; 96():103283. PubMed ID: 34020864
[TBL] [Abstract][Full Text] [Related]
3. Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction.
Hallinan R; Byrne A; Dore GJ
Drug Alcohol Rev; 2007 Jul; 26(4):437-43. PubMed ID: 17564882
[TBL] [Abstract][Full Text] [Related]
4. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
[TBL] [Abstract][Full Text] [Related]
5. Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C.
Schranz AJ; Barrett J; Hurt CB; Malvestutto C; Miller WC
Curr HIV/AIDS Rep; 2018 Jun; 15(3):245-254. PubMed ID: 29796965
[TBL] [Abstract][Full Text] [Related]
6. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.
Springer SA; Nijhawan AE; Knight K; Kuo I; Di Paola A; Schlossberg E; Frank CA; Sanchez M; Pankow J; Proffitt RP; Lehman W; Pulitzer Z; Thompson K; Violette S; Harding KK;
BMC Infect Dis; 2022 Apr; 22(1):380. PubMed ID: 35428213
[TBL] [Abstract][Full Text] [Related]
7. Strengthening systems of care for people with or at risk for HIV, HCV and opioid use disorder: a call for enhanced data collection.
Eller AJ; DiDomizio EE; Madden LM; Oliva JD; Altice FL; Johnson KA
Ann Med; 2022 Dec; 54(1):1714-1724. PubMed ID: 35775786
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV.
Tsui JI; Akosile MA; Lapham GT; Boudreau DM; Johnson EA; Bobb JF; Binswanger IA; Yarborough BJH; Glass JE; Rossom RC; Murphy MT; Cunningham CO; Arnsten JH; Thakral M; Saxon AJ; Merrill JO; Samet JH; Bart GB; Campbell CI; Loree AM; Silva A; Stotts AL; Ahmedani B; Braciszewski JM; Hechter RC; Northrup TF; Horigian VE; Bradley KA
J Gen Intern Med; 2021 Apr; 36(4):930-937. PubMed ID: 33569735
[TBL] [Abstract][Full Text] [Related]
9. Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk.
Brinkley-Rubinstein L; Cloud D; Drucker E; Zaller N
Curr HIV/AIDS Rep; 2018 Jun; 15(3):255-258. PubMed ID: 29752698
[TBL] [Abstract][Full Text] [Related]
10. The furthest left behind: the urgent need to scale up harm reduction in prisons.
Sander G; Murphy F
Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
[TBL] [Abstract][Full Text] [Related]
11. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study.
Ochalek TA; Heil SH; Higgins ST; Badger GJ; Sigmon SC
Drug Alcohol Depend; 2018 Sep; 190():224-228. PubMed ID: 30056321
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of HCV and HIV infection among clients of the nation's longest-standing statewide syringe exchange program: A cross-sectional study of Community Health Outreach Work to Prevent AIDS (CHOW).
Salek TP; Katz AR; Lenze SM; Lusk HM; Li D; Des Jarlais DC
Int J Drug Policy; 2017 Oct; 48():34-43. PubMed ID: 28779632
[TBL] [Abstract][Full Text] [Related]
13. "No more falling through the cracks": A qualitative study to inform measurement of integration of care of HIV and opioid use disorder.
Oldfield BJ; Muñoz N; Boshnack N; Leavitt R; McGovern MP; Villanueva M; Tetrault JM; Edelman EJ
J Subst Abuse Treat; 2019 Feb; 97():28-40. PubMed ID: 30577897
[TBL] [Abstract][Full Text] [Related]
14. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
Brown JL; Gause NK; Lewis D; Winhusen T
J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
[TBL] [Abstract][Full Text] [Related]
15. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
[TBL] [Abstract][Full Text] [Related]
16. Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment.
Havens JR; Walsh SL; Korthuis PT; Fiellin DA
Curr HIV/AIDS Rep; 2018 Aug; 15(4):315-323. PubMed ID: 29948609
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
18. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
[TBL] [Abstract][Full Text] [Related]
20. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
